ARGS's Business Model
None
| Sector & Industry | Healthcare / Biotechnology |
| Website | http://www.argostherapeutics.com |
| CEO (Chief Executive Officer) | None |
| Number of Employees | |
| IPO date | February 7, 2014 |
ARGS Latest News
|
|
|
|
|
|
|
|
|
|
| Contact | |
|---|---|
| Country | US |
| Address | 4233 Technology Drive |
| City | Durham |
| State | None |
| Phone | (919) 287-6300 |
| Zip Code | None |
| Other Identifiers | |
| CIK | 0001105533 |
| ISIN | None |
| CUSIP | None |
| Open | 0.265 |
| Previous Close | 0.2701 |
| Volume | 759 Thou. |
| Average Volume | 2.63 Mil. |
| Day’s Range | 0.25 – 0.2849 |
| 52 Week Range | 3.89-0.1251 |
| MA (50) | 1.12 |
| MA (200) | 0.57364 |
| Market Cap | 0 |
| Shares Out. | 0 |
| Earnings Date | Sep 30, 2018 |
| Beta | |
| Last Dividend | |
| EPS | |
| PE | |
